These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 32623096

  • 1. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
    Steinhoff BJ, Christensen J, Doherty CP, Majoie M, De Backer M, Hellot S, Leunikava I, Leach JP.
    Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial.
    Inoue Y, Tiamkao S, Zhou D, Cabral-Lim L, Lim KS, Lim SH, Tsai JJ, Moseley B, Wang L, Sun W, Hayakawa Y, Sasamoto H, Sano T, McClung C, Bass A.
    Epilepsia Open; 2024 Jun; 9(3):1007-1020. PubMed ID: 38576178
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [Abstract] [Full Text] [Related]

  • 7. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
    Arnold S, Laloyaux C, Schulz AL, Elmoufti S, Yates S, Fakhoury T.
    Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
    [Abstract] [Full Text] [Related]

  • 8. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
    Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P.
    Epilepsia; 2016 Jul; 57(7):1139-51. PubMed ID: 27265725
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis.
    Moseley BD, Dimova S, Elmoufti S, Laloyaux C, Asadi-Pooya AA.
    Epilepsy Res; 2021 Oct; 176():106694. PubMed ID: 34218211
    [Abstract] [Full Text] [Related]

  • 10. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C, Dimova S, Elmoufti S, Laloyaux C, Nondonfaz X, Klein P.
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD, Sperling MR, Asadi-Pooya AA, Diaz A, Elmouft S, Schiemann J, Whitesides J.
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [Abstract] [Full Text] [Related]

  • 13. BRIVEST: A 'real-world' observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam.
    Naddell S, Manuel M, Cavill R, White P, Sieradzan K.
    Epilepsy Behav; 2023 Jan; 138():108985. PubMed ID: 36442261
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
    O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V.
    Epilepsia; 2020 Apr; 61(4):636-646. PubMed ID: 32221987
    [Abstract] [Full Text] [Related]

  • 15. Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies.
    Brodie MJ, Whitesides J, Schiemann J, D'Souza J, Johnson ME.
    Epilepsy Res; 2016 Nov; 127():114-118. PubMed ID: 27589414
    [Abstract] [Full Text] [Related]

  • 16. Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies.
    Faught E, Besson H, D'Souza W, Klein P, Reuber M, Rosenow F, Salas-Puig J, Insuga VS, Steinhoff BJ, Strzelczyk A, Szaflarski JP, Bourikas D, Daniels T, Floricel F, Friesen D, Laloyaux C, Villanueva V.
    Epilepsy Behav; 2024 Sep; 158():109922. PubMed ID: 38970892
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
    Van Paesschen W, Hirsch E, Johnson M, Falter U, von Rosenstiel P.
    Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
    Stephen L, Brodie MJ.
    Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
    [Abstract] [Full Text] [Related]

  • 19. Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials.
    Patel AD, Badalamenti V, Gasalla T, Elmoufti S, Elshoff JP.
    Eur J Paediatr Neurol; 2020 Mar; 25():68-76. PubMed ID: 31810577
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
    Klein P, Schiemann J, Sperling MR, Whitesides J, Liang W, Stalvey T, Brandt C, Kwan P.
    Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.